The effect of altering heart rate on ventricular function in patients with heart failure treated with beta-blockers

Simon D R Thackray1, Justin M Ghosh, Graham A Wright

  • 1Department of Academic Cardiology, University of Hull, Castle Hill Hospital, Kingston-upon-Hull, United Kingdom. simonthackray@hotmail.com

American Heart Journal
|September 26, 2006
PubMed

Insights

Beta-blocker therapy for heart failure may work by slowing heart rate. Increasing heart rate in pacemaker patients on beta-blockers worsened heart function, suggesting rate reduction is key.

Area of Science:

  • Cardiology
  • Pharmacology
  • Biomedical Engineering

Background:

  • Beta-blockers are established heart failure treatments, but their precise mechanism of action remains unclear.
  • Heart rate reduction, a common effect of beta-blockers, is debated as either a therapeutic mechanism or a side effect.

Purpose of the Study:

  • To investigate the role of heart rate reduction in the efficacy of beta-blocker treatment for heart failure.
  • To compare the effects of higher-rate versus lower-rate pacing on left ventricular (LV) remodeling in pacemaker-dependent patients receiving beta-blockers.

Main Methods:

  • A randomized, double-blind, parallel-group study was conducted.
  • Patients with symptomatic LV systolic dysfunction on beta-blockers underwent chronic pacing at 80 bpm (higher-rate) or 60 bpm (lower-rate).
  • Gated radionuclide ventriculography assessed LV volumes and ejection fraction at baseline and after 9 months.

Main Results:

  • Higher-rate pacing led to significant increases in LV end-diastolic and systolic volumes compared to lower-rate pacing.
  • LV ejection fraction declined with higher-rate pacing but improved slightly with lower-rate pacing.
  • A significant proportion of patients (43%) died during follow-up, highlighting poor prognosis.

Conclusions:

  • Reversing beta-blocker-induced bradycardia by increasing pacing rate has detrimental effects on ventricular function.
  • These findings suggest that heart rate reduction is a crucial mediator of beta-blockers' beneficial effects in heart failure.
  • Patients with pacemakers and heart failure exhibit a poor prognosis, underscoring the need for effective management strategies.
Abstract

Related Concept Videos

Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Cardiac Output I:Effect of Heart Rate on Cardiac Output01:19

Cardiac Output I:Effect of Heart Rate on Cardiac Output

Cardiac Output
Cardiac output (CO) refers to the total amount of blood ejected by one of the ventricles in liters per minute (L/min). In a resting adult, CO ranges from 5 to 6 L/min, adjusting according to the body's metabolic requirements.
Effect of Heart Rate on Cardiac Output
Cardiac output adapts to metabolic demands during stress, physical activity, or illness. The autonomic nervous system regulates heart rate via the sinoatrial node. The parasympathetic nervous system decreases heart rate...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...